Kristopher Kramer, Robin Kindt, Robert Ford, Reo Ford, and Teesha Lee Ford v. Metropolitan Life Insurance Company

CourtDistrict Court, D. Utah
DecidedNovember 13, 2025
Docket2:25-cv-00327
StatusUnknown

This text of Kristopher Kramer, Robin Kindt, Robert Ford, Reo Ford, and Teesha Lee Ford v. Metropolitan Life Insurance Company (Kristopher Kramer, Robin Kindt, Robert Ford, Reo Ford, and Teesha Lee Ford v. Metropolitan Life Insurance Company) is published on Counsel Stack Legal Research, covering District Court, D. Utah primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Kristopher Kramer, Robin Kindt, Robert Ford, Reo Ford, and Teesha Lee Ford v. Metropolitan Life Insurance Company, (D. Utah 2025).

Opinion

UNITED STATES DISTRICT COURT DISTRICT OF UTAH

KRISTOPHER KRAMER, ROBIN MEMORANDUM DECISION & KINDT, ROBERT FORD, REO FORD, ORDER GRANTING PLAINTIFFS’ and TEESHA LEE FORD, MOTION FOR LEAVE TO CONDUCT LIMITED DISCOVERY IN PART Plaintiffs, Case No. 2:25-cv-00327 v. District Court Judge Howard C. Nielson METROPOLITAN LIFE INSURANCE COMPANY, Magistrate Judge Dustin B. Pead

Defendant.

INTRODUCTION Plaintiffs Kristopher Kramer, Robin Kindt, Robert Ford, Reo Ford and Teesha Lee Ford (collectively, “Plaintiffs”) motion the court to conduct limited discovery regarding Defendant Metropolitan Life Insurance Company’s (“Defendant” or “MetLife”) dual role as both the plan administer and the payor of benefits on Plaintiffs’ claims.1 MetLife objects to any additional discovery, arguing Plaintiffs fail to meet their burden of identifying specific reasons as to why additional discovery is necessary.2 Upon review and for the reasons now stated herein, the court GRANTS Plaintiffs’ Motion IN PART.3

1 ECF No. 20, Plaintiffs’ Motion for Leave to Conduct Limited Discovery (“Motion”). 2 ECF No. 29 at 2, Defendant’s Motion for Leave to Conduct Limited Discovery. 3 ECF No. 20. BACKGROUND Decedent was an employee at Wells Fargo Bank who participated in the bank’s employee welfare benefits program.4 The program included life insurance and accidental death and dismemberment (“AD&D”) benefits (“Plan”).5 Decedent passed away on February 4, 2021, due to “[d]rug intoxication; oxycodone, venlafaxine, amphetamine, etizolam and mitragynine”.6 Under decedent’s Plan, MetLife paid out basic life insurance benefits.7 Thereafter, Plaintiffs submitted two additional claims: a $600,000 AD&D benefit (“First Claim”); and a $75,000 AD&D benefit (“Second Claim”).8 After review, MetLife denied both claims based on the Plan’s language excluding coverage for the “voluntary intake or use by any means of . . . any drug, medication or sedative, unless it is: taken or used as prescribed by a Physician . . . .”9

MetLife concluded decedent did not have a valid prescription for oxycodone and therefore decedent’s “death was caused/contributed to by a drug that was not taken as prescribed.” 10 Plaintiffs’ appealed MetLife’s denial of claims and submitted evidence of decedent’s past oxycodone prescriptions issued in 2018 and 2019.11 In response, MetLife retained independent

4 29 U.S.C. § 1132(d)(1) (defining employee benefit plan). 5 ECF No. 1 at ¶ 9, Complaint; ECF No. 29-1, Exhibit A, MetLife Certificate of Insurance. 6 ECF No. 29-2, Exhibit B, Certificate of Death. 7 ECF No. 29-3, Exhibit C, Claim Summary. 8 Id. 9 ECF No. 29-1, Exhibit A at 43-44, AR_000112-AR-000113, Accidental Death and Dismemberment Exclusions. 10 ECF No. 29-4, Exhibit D at 1-12, AR_000364-AR_000381, November 5, 2021 denial of benefits letters. 11 ECF No. 29-5, Exhibit E, Discharge Summary. physician reviewer, Dr. Michael A. Darracq (“Dr. Darracq”), to conduct an outside medical review.12 Dr. Darracq determined decedent’s oxycodone prescriptions were not current and, for the first time, asserted that the drug venlafaxine was present at toxic levels exceeding decedent’s prescription dosage.13 Based on the conclusions set forth in Dr. Darracq’s independent review, MetLife upheld its denial of Plaintiffs’ First and Second Claims.14 In February 2024, Plaintiffs asked MetLife to reconsider their claims and provided their own toxicology consultant report from Dr. Patricia Williams (“Dr. Williams”).15 In her report, Dr. Williams refuted the assertion that decedent was taking venlafaxine or oxycodone in a manner not prescribed by a physician.16 Dr. Williams further explained that decedent had been prescribed oxycodone “as needed” meaning that decedent’s prescription was valid over an

extended period of time.17 After receiving the report from Dr. Williams, MetLife denied Plaintiffs’ appeal of the Second Claim and refused to reconsider its denial of an appeal for Plaintiffs’ First Claim.18 Plaintiffs filed their pending action against MetLife on April 25, 2025.19 On September 15, 2025, Plaintiffs moved to conduct limited discovery related to MetLife’s inherent conflict of

12 ECF No. 29-6, Exhibit F, Dr. Michael A. Darracq’s Peer Review Report. 13 Id. 14 ECF No. 29-7, Exhibit G at 1-5, AR_000402-AR_000403, January 14, 2022, denial of benefits letters. 15 ECF No. 30-1, Exhibit A, Dr. Patricia Williams Report. 16 Id. 17 Id. 18 ECF No. 30 at 3. 19 ECF No. 1. interest based on its role as both the payor of decedent’s benefits and as the entity determining Plaintiffs’ entitlement to those benefits.20 LEGAL STANDARD The Employment Retirement Income Security Act (“ERISA”) allows an individual, who is denied benefits under an employee benefits plan, to challenge that denial in federal court.21 Generally, judicial review of an ERISA claim is “limited to the administrative record—the materials compiled by the administrator in the course of making his [or her] decision.”22 In certain cases, however, “the entity that administers the plan, such as an employer or an insurance company, [not only] determines whether an employee is eligible for benefits[, but also] pays benefits out of its own pocket.”23 In these “dual role conflict” cases, courts may permit discovery

outside the administrative record so as to determine the “scope and impact” of the conflict.24 The

20 ECF No. 20. 21 29 U.S.C. § 1001 et seq. 22 Holcomb v. UNUM Life Insurance Company of America, 578 F.3d 1187, 1192 (10th Cir. 2009) (quoting Fought v. UNUM Life Insurance Company of America, 379 F. 3d 997, 1003 (10th Cir. 2004)). 23 Metro Life Insurance Company v. Glenn, 554 U.S. 105, 108, 128 S. Ct. 2343, 171 L. Ed. 2d 299 (2008). 24 Murphy v. Deloitte & Touche Group Insurance Plan, 619 F.3d 1151, 1162 (10th Cir. 2010); see also Glenn, 554 U.S. at 105; Paul v. Hartford Life and Accident Insurance Company, 2008 U.S. Dist. LEXIS 59986, at *7 (D. Colo. July 28, 2008) (“while it would not be proper to allow Plaintiff to conduct discovery related to the factual merits of his claim, this Court will permit limited discovery related to the alleged conflict of interest in this case and to the policies and procedures used by [the administrator] to make its decision.”). party “moving to supplement the record or engage in extra-record discovery bears the burden of showing [the extra-record discovery’s] propriety.”25 District Court’s have substantial discretion in handling discovery requests under Federal Rule of Civil Procedure 26(b).26 In determining whether dual conflict discovery is appropriate the court must consider the “familiar standards” of Federal Rule of Civil Procedure 26.27 By doing so, the court ensures that the requested discovery comports with ERISA’s focus on prompt claims’ resolution, while balancing the cost and burden of the discovery in light of its asserted necessity.28 ANALYSIS With the above stated legal principles in mind, the court finds Plaintiffs’ request for

limited, extra-record discovery in this action is appropriate. Conflicting medical reports and the inability to challenge newly raised medical claims creates ambiguity.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
Kristopher Kramer, Robin Kindt, Robert Ford, Reo Ford, and Teesha Lee Ford v. Metropolitan Life Insurance Company, Counsel Stack Legal Research, https://law.counselstack.com/opinion/kristopher-kramer-robin-kindt-robert-ford-reo-ford-and-teesha-lee-ford-utd-2025.